Jacobio's self-developed global first-in-class drug Aurora A inhibitor JAB-2485 received IND (Investigational New Drug) from the FDA (Food and Drug Administration) in US. Jacobio...
On January 13, 2022, Green Valley (Shanghai) Pharmaceuticals Co., Ltd. received the letter from the US Food and Drug Administration (FDA) on the Investigational...
CARsgen Therapeutics Holdings Limited , a company mainly focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced...
Wanxiang Blockchain marked the start of a promising 2022 with its next-generation blockchain technology platform "Vena Consortium". Built upon PlatONE, a consortium blockchain featuring...
Antengene Corporation Limited, a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and other life-threatening...
